Neovasc Inc. Reports Financial Results for First Quarter of 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

VANCOUVER, May 28, 2013 — --Increased Year-over-Year Revenues by 17%, Driven by Growth in Contract Manufacturing and Consulting Services to Transcatheter Heart Valve Customers-- --Completed Patient Enrollment in Neovasc Reducer™ COSIRA Trial-- --Presented Positive Reducer and Tiara™ Mitral Valve Program Data at 2013 EuroPCR--

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC